Health
Report warns of 'worryingly thin' antimicrobial treatments pipeline
Amsterdam-based NGO Access To Medicine Foundation (AMF) has published the fourth edition of its Antimicrobial Resistance Benchmark report. Chief Executive Officer, Jayasree K. Iyer, says that there are some positive signs with recent regulatory approvals for three antibiotics with innovative characteristics and seven promising products in late-stage development, but that overall the pipeline remains “worryingly thin” and far from picking up pace “industry investment has lost momentum”.
Smaller firms filling innovation gap
The report covers 25 companies, including large and - for the first time - small companies, and ten generic manufacturers. It focuses on three main areas: R&D, responsible manufacturing and appropriate access and stewardship.
The authors estimate that the number of projects from large research-based pharmaceutical companies has declined by 35% between...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Sport3 days agoWho will win the 2026 World Cup? Data points to Spain
-
Russia5 days agoWestern investors eye Russian assets again as sanctions discounts persist
-
Green Week5 days agoEU green jobs: Which activities employ the most people?
-
EU5 days agoGovernment gross debt of eurozone largely in euro
